Japanese Insurance Stock News

TSE:6479
TSE:6479Machinery

MINEBEA MITSUMI (TSE:6479) Lifts Profit Guidance Following Upgrade Is The Stock Fully Valued

Why the latest guidance change at MINEBEA MITSUMI matters MINEBEA MITSUMI (TSE:6479) has raised its earnings guidance for the six months to September 30, 2026 and the full year to March 31, 2027, lifting projected profit attributable to owners of parent. For the first half, the company still expects net sales of ¥846.5b and operating income of ¥53.0b. The updated outlook now points to profit attributable to owners of parent of ¥40.5b and basic earnings per share of ¥100.85, compared with the...
TSE:5332
TSE:5332Building

TOTO (TSE:5332) Lifts Guidance And Dividend Following A Pullback But Fair Value Still Looks Higher

TOTO (TSE:5332) has issued new guidance for the six months to September 30, 2026, and for the full fiscal year to March 31, 2027, along with updated expectations for interim and year-end dividends. See our latest analysis for TOTO. The new guidance arrives after a mixed stretch for the stock, with a 1 day share price return of 5.54% but a 30 day share price return that declined 22.30%. At the same time, the year to date share price return of 51.48% and 1 year total shareholder return of...
TSE:7751
TSE:7751Tech

Canon (TSE:7751) Could Be 33% Undervalued After Half Year Earnings

Why Canon earnings matter for current shareholders Canon (TSE:7751) drew fresh attention after reporting half year 2026 results, with sales of ¥2,274,542 million and net income of ¥171,184 million compared with the same period a year earlier. See our latest analysis for Canon. Canon's latest half year earnings arrived after a period where the stock posted a 10.29% 90 day share price return. The 1 year total shareholder return of 7.04% and 5 year total shareholder return of 104.28% point to...
TSE:6941
TSE:6941Semiconductor

Yamaichi ElectronicsLtd (TSE:6941) Board Meeting Puts Valuation In Focus As Forecast Revision Looms

Board meeting puts Yamaichi ElectronicsLtd (TSE:6941) earnings outlook in focus Yamaichi ElectronicsLtd (TSE:6941) has called a board meeting for 5 August 2026 to revise its interim and full year consolidated earnings forecasts for the fiscal year ending 31 March 2027. The update will be based on recent business performance trends and the current outlook. This often draws investor attention because it can reshape expectations for earnings, valuation and share price risk around the stock. See...
TSE:5038
TSE:5038Healthcare Services

3 Japanese AI Healthcare Stocks Trading Below Fair Value

Services and manufacturing activity are picking up across Europe and Asia, with inflation pressures easing and central banks signalling more flexibility. That mix often pulls attention toward growth themes that can scale as demand firms. Transformative AI healthcare stocks sit right in that spotlight, using data and algorithms to reshape treatment and research. This article highlights three stocks from the screener that show how this theme is playing out today. The three stocks below are only...
TSE:8035
TSE:8035Semiconductor

Tokyo Electron (TSE:8035) Could Be 19% Below Fair Value As It Lifts Guidance and Dividend

Tokyo Electron (TSE:8035) recently raised its first half earnings guidance, reported higher first quarter sales and net income year over year, and lifted interim dividend expectations, giving investors fresh information to reassess the stock. See our latest analysis for Tokyo Electron. Tokyo Electron’s raised guidance and higher interim dividend come alongside a 7 day share price return of 17.10% and a year to date share price return of 58.54%, while the 1 year total shareholder return of...
TSE:4635
TSE:4635Chemicals

Top Asian Dividend Stocks To Consider In August 2026

As the Asian markets navigate a landscape marked by global economic uncertainties and evolving geopolitical dynamics, investors are increasingly focusing on strategies that offer stability and income. In this context, dividend stocks emerge as a compelling option, providing potential for steady returns amidst market fluctuations.